High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years
Size: It is among the top 200 market size companies of india.
Balance Sheet: Strong Balance Sheet.
Profitability: Very strong Profitability. One year profit margin are 16%.
Smart Money: Smart money has been increasing their position in the stock.
Growth: Good revenue growth. With 80.1% growth over past three years, the company is going strong.
Past Returns: Outperforming stock! In past three years, the stock has provided 24.6% return compared to 7.8% by NIFTY 50.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Momentum: Stock is suffering a negative price momentum. Stock is down -8.5% in last 30 days.
Technicals: SharesGuru indicator is Bearish.
Valuation | |
|---|---|
| Market Cap | 98.16 kCr |
| Price/Earnings (Trailing) | 67.28 |
| Price/Sales (Trailing) | 11.06 |
| EV/EBITDA | 41.44 |
| Price/Free Cashflow | 659.73 |
| MarketCap/EBT | 57.36 |
| Enterprise Value | 1.01 LCr |
Fundamentals | |
|---|---|
| Revenue (TTM) | 8.88 kCr |
| Rev. Growth (Yr) | 16.6% |
| Earnings (TTM) | 1.46 kCr |
| Earnings Growth (Yr) | 4.9% |
Profitability | |
|---|---|
| Operating Margin | 20% |
| EBT Margin | 19% |
| Return on Equity | 13.56% |
| Return on Assets | 8.46% |
| Free Cashflow Yield | 0.15% |
Growth & Returns | |
|---|---|
| Price Change 1W | -5.7% |
| Price Change 1M | -8.5% |
| Price Change 6M | -4.3% |
| Price Change 1Y | -17.4% |
| 3Y Cumulative Return | 24.6% |
| 5Y Cumulative Return | 25.9% |
Cash Flow & Liquidity | |
|---|---|
| Cash Flow from Investing (TTM) | -1.69 kCr |
| Cash Flow from Operations (TTM) | 1.63 kCr |
| Cash Flow from Financing (TTM) | 59.27 Cr |
| Cash & Equivalents | 665.8 Cr |
| Free Cash Flow (TTM) | 148.79 Cr |
| Free Cash Flow/Share (TTM) | 1.53 |
Balance Sheet | |
|---|---|
| Total Assets | 17.23 kCr |
| Total Liabilities | 6.48 kCr |
| Shareholder Equity | 10.75 kCr |
| Current Assets | 1.94 kCr |
| Current Liabilities | 2.19 kCr |
| Net PPE | 6.98 kCr |
| Inventory | 114.28 Cr |
| Goodwill | 3.49 kCr |
Capital Structure & Leverage | |
|---|---|
| Debt Ratio | 0.2 |
| Debt/Equity | 0.32 |
| Interest Coverage | 5.81 |
| Interest/Cashflow Ops | 7.5 |
Dividend & Shareholder Returns | |
|---|---|
| Dividend/Share (TTM) | 2 |
| Dividend Yield | 0.20% |
| Shares Dilution (1Y) | 0.10% |
| Shares Dilution (3Y) | 0.20% |
High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years
Size: It is among the top 200 market size companies of india.
Balance Sheet: Strong Balance Sheet.
Profitability: Very strong Profitability. One year profit margin are 16%.
Smart Money: Smart money has been increasing their position in the stock.
Growth: Good revenue growth. With 80.1% growth over past three years, the company is going strong.
Past Returns: Outperforming stock! In past three years, the stock has provided 24.6% return compared to 7.8% by NIFTY 50.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Momentum: Stock is suffering a negative price momentum. Stock is down -8.5% in last 30 days.
Technicals: SharesGuru indicator is Bearish.
Investor Care | |
|---|---|
| Dividend Yield | 0.20% |
| Dividend/Share (TTM) | 2 |
| Shares Dilution (1Y) | 0.10% |
| Earnings/Share (TTM) | 14.99 |
Financial Health | |
|---|---|
| Current Ratio | 0.89 |
| Debt/Equity | 0.32 |
Technical Indicators | |
|---|---|
| RSI (14d) | 18.34 |
| RSI (5d) | 7.95 |
| RSI (21d) | 32.14 |
| MACD Signal | Sell |
| Stochastic Oscillator Signal | Buy |
| SharesGuru Signal | Sell |
| RSI Signal | Buy |
| RSI5 Signal | Buy |
| RSI21 Signal | Hold |
| SMA 5 Signal | Sell |
| SMA 10 Signal | Sell |
| SMA 20 Signal | Sell |
| SMA 50 Signal | Sell |
| SMA 100 Signal | Sell |
Summary of Max Healthcare Institute's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.
In the earnings call held on May 22, 2026, management provided an optimistic outlook for Max Healthcare, emphasizing their expansion and growth strategies. Key forward-looking points included:
Commissioning of Additional Capacity: Management highlighted the phased commissioning of over 20% additional brownfield capacity in Mohali, Nanavati (Mumbai), and Max Smart (Delhi), with full operationalization expected in the next 2-3 months. They will add another 10% capacity with a new 500-bed greenfield hospital in Gurgaon set to be operational by the end of FY '27.
Strategic Acquisition: Management completed the acquisition of Kalinga Hospital, a 250-bed facility in Bhubaneswar, enhancing their presence in Eastern India. This acquisition is expected to contribute positively to their growth with plans for facility revamping and expansion.
Investment Plans: The Board approved an investment of INR 1,400 crore for a new 700-bed greenfield hospital in Lucknow, anticipating strong demand for healthcare services in the region.
Financial Performance Metrics: For Q4, consolidated revenue grew by 10% year-on-year to INR 2,664 crore, with operating EBITDA increasing by 8% to INR 682 crore. The annualized EBITDA per bed stood at INR 73 lakh.
Future Growth Projections: Management expressed confidence in continuing revenue growth driven by high occupancy rates (above 75%) and increasing average revenue per occupied bed (ARPOB), which was INR 77,900 for the quarter.
Community Support: The company provided free treatment worth INR 59 crore to approximately 42,000 patients from economically weaker sections, underscoring its commitment to community welfare.
Overall, management's focus for FY '27 will be on scaling existing capacities, integrating new acquisitions, and maintaining strong operational performance amidst upcoming expansion projects.
I'm sorry, but there is no attached earnings transcript that I can refer to. If you provide the text of the transcript or specific sections, I'd be happy to help summarize the major questions and answers for you.
Understand Max Healthcare Institute ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.
| Shareholder Name | Holding % |
|---|---|
| Abhay Soi | 23.71% |
| Nps Trust A/C through various schemes | 3.45% |
| New World Fund Inc | 3.29% |
| Government Of Singapore | 3.28% |
| Hdfc Mutual Fund through various schemes | 3.04% |
| Life Insurance Corporation of India through various schemes | 3% |
| SBI Mutual Fund through various schemes | 2.55% |
| Invesco Mutual Fund through various schemes | 2.19% |
| ICICI Prudential Mutual Fund through various schemes | 1.69% |
| Nippon India Mutual Fund through various schemes | 1.53% |
| Axis Max Life Insurance Limited through various schemes | 1.46% |
| Canara Robeco Mutual Fund through various schemes | 1.43% |
| Smallcap World Fund, Inc | 1.35% |
| Government Pension Fund Global | 1.16% |
| Vanguard Total International Stock Index Fund | 1.12% |
| Vanguard Emerging Markets Stock Index Fund, a Series of Vanguard International Equity Index Funds | 1.06% |
| Motilal Oswal Midcap Fund | 1.04% |
| Monetary Authority of Singapore | 1% |
| Aditya Soi | 0.01% |
| Taruna Soi | 0% |
Distribution across major stakeholders
Distribution across major institutional holders
Detailed comparison of Max Healthcare Institute against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.
Ticker | Name | Mkt Cap | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|---|
| APOLLOHOSP | Apollo Hospitals Enterprises | 1.28 LCr | 26.63 kCr | -0.20% | +14.10% | 61.38 | 4.82 | - | - |
| FORTIS | Fortis Healthcare | 70.14 kCr | 9.56 kCr | -4.80% | -0.30% | 66.93 | 7.34 | - | - |
| MEDANTA | Global Health | 38.25 kCr | 4.78 kCr | +6.30% | +3.50% | 68.72 | 8 | - | - |
| NH | Narayana Hrudayalaya | 37.45 kCr | 9.18 kCr | -10.00% | +1.10% | 45.61 | 4.08 | - | - |
| KIMS | Krishna Institute of Medical Sciences | 33.98 kCr | 4.25 kCr | +0.10% | +8.60% | 158.65 | 8 | - | - |
| SHALBY | Shalby | 1.65 kCr | 1.2 kCr | -9.10% | -24.80% | 43.69 | 1.37 | - | - |
Comprehensive comparison against sector averages
MAXHEALTH metrics compared to Healthcare
| Category | MAXHEALTH | Healthcare |
|---|---|---|
| PE | 67.28 | 67.52 |
| PS | 11.06 | 6.58 |
| Growth | 15.7 % | 20.8 % |
Max Healthcare Institute is a prominent hospital company in India, reflecting its substantial presence in the healthcare sector with a stock ticker of MAXHEALTH and a market capitalization of Rs. 106,915.1 Crores.
The company offers a wide range of medical and healthcare services across various specialties, which include:
Max Healthcare also specializes in organ transplants, such as liver, heart, kidney, lung, and bone marrow transplants.
In addition to its hospital services, Max Healthcare has developed two key platforms:
Established in 2001 and headquartered in Gurugram, India, Max Healthcare operates a comprehensive network of healthcare facilities, including hospitals and medical centers.
The company has demonstrated strong financial performance, reporting a trailing 12 months revenue of Rs. 6,695.7 Crores and generating a profit of Rs. 1,008.4 Crores over the past four quarters. Over the last three years, Max Healthcare has achieved a remarkable 70.4% revenue growth.
Investors benefit from dividends, with a yield of 0.26% per year and a recent payout of Rs. 2.5 per share. However, there have been instances of share dilution, with a 0.3% dilution of shareholder equity in the past three years.
Overall, Max Healthcare Institute is a profitable and growing entity in the healthcare sector, committed to delivering diverse medical services and enhancing patient care both within and outside its facilities.
This is an informational page just to provide a quick 'first look' at the stock. You must do your own deeper research. Know your risk appetite. Consult a SEBI-registered financial advisor before making any investment decisions.
MAXHEALTH vs Healthcare (2021 - 2026)